Skip to main content

Table 1 Characteristics of subjects enrolled in the study

From: Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis

 

TB Patients

(n = 23)

Healthy Controls

(n = 21)

Median Age (range)

27 (22–66)

25 (20–33)

Male, n (%)

16 (59.3%)

13 (62.0%)

Presence of BCGa scars

15 (65.2%)

12 (57.1%)

PTBb diagnosis

AFBc smear, positive

0 (0.0%)

0 (0.0%)

AFBc culture, positive

19 (82.6%)

0 (0.0%)

Cavity on Chest X-ray or CTd

8 (34.8%)

0 (0.0%)

Risk group for relapse

High-risk

0 (0.0%)

0 (0.0%)

Moderate-risk

8 (34.8%)

0 (0.0%)

Low-risk

15 (65.2%)

0 (0.0%)

  1. aBCG Bacille Calmette-Guérin, b PTB Pulmonary tuberculosis, c AFB Acid-fast bacillus; d CT Computed tomography. Risk factors for relapse: i) the presence of a cavity lesion on chest X-ray or chest CT, and ii) the result of a positive sputum culture after 2 months of anti-TB treatment. The high-risk group was defined when patients had both risk factors i) and ii). The moderate-risk group was defined when patients had either risk factor i) or ii), and the low-risk group had neither risk factor
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us